|
Molecular mechanisms of sensitivity and resistance towards chemotherapeutics in most frequent solid cancers
Čumová, Andrea ; Vodička, Pavel (advisor) ; Černá, Marie (referee) ; Hlaváč, Viktor (referee)
Despite the great effort, the main obstacle to cancer therapy represents low response towards common chemotherapeutics and/or resistance. Chemoresistance causes cancer relapse and formation of metastases, dramatically challenging the prognosis of patients. It is estimated, that about 90% of cancer mortality can be directly or indirectly attributed to chemoresistance. There are several intrinsic or acquired cellular mechanisms of tumor chemoresistance, with DNA repair being one of the key culprits affecting the response towards chemotherapeutics in cancer cells. This is based on the fundamental principle of their action, as the majority of chemotherapeutics are designed to increase DNA damage and to suppress DNA repair or DNA damage response, ultimately triggering the death of malignant cells. Consequently, understanding the complex mechanisms of DNA repair and its regulation is essential for more targeted and effective treatment of cancer patients. In this dissertation Thesis, we attempted to elucidate some of the regulatory mechanisms of DNA repair and their effects on response to common chemotherapeutics. We confirmed that single nucleotide polymorphisms in microRNA binding sites of DNA repair genes may influence the patient's survival and response to cancer therapy. We investigated the role of...
|
|
A study of chemoresistance in patients with colorectal cancer treated with 5-fluorouracil
Dostál, Petr ; Vymetálková, Veronika (advisor) ; Šeborová, Karolína (referee)
The choice of treatment strategy in patients with malignant disease depends on various clinical and molecular biological factors. Although several molecular predictive biomarkers have already been proposed, only a few of them are used in clinical practice and the number is still not enough for reliable personalized medicine. Given the lack of treatment success results in many colorectal cancer (CRC) patients, there is an urgent need for personalized medicine to identify new predictive biomarkers. One of the main clinical challenges in the treatment of advanced CRC is the development of chemoresistance to systematic chemotherapy. Early detection of resistant cancer cells clones could lead to changes in treatment regimens but it requires a long-term follow up of patients and monitoring of specific markers of chemoresistance. The aim of this master's thesis has been to determine the biomarkers associated with chemoresistance to 5-FU drug, one of the most used chemotherapeutics in the treatment of CRC patients. In the first step, the whole transcriptome of maternal (sensitive) and resistant DLD-1 (line resistant to 40 µM 5-FU and line resistant to 160 µM 5-FU) cell lines using the next generation sequencing (NGS) has been analyzed. Through bioinformatic analyses, potential candidate genes (HIST1H2BE,...
|
|
Optimization of 5-fluorouracil determination by high-performance liquid chromatography
Durychová, Eva ; Křížek, Tomáš (advisor) ; Kozlík, Petr (referee)
This thesis is dedicated to the development of a method for the determination of 5-fluorouracil by high-performance liquid chromatography, which could be used for determination of its encapsulation efficiency by liposomes. First, separation of 1 mM standard of 5-fluorouracil was tested on several types of columns. Among tested columns belonged a C18 column, a C18 column with positive surface modification, a phenyl-hexyl column and several fluoride columns together with two HILIC columns. A mixture containing 10 mM CH3COONH4, pH = 4,5 and MeOH in the ratio of 98/2 was initially used as the mobile phase. The results showed, that 5-fluorouracil elutes on all columns too close to the dead time, where different impurities often elute. To avoid possible distortion of 5-fluorouracil signal by impurities potentially occurring in the real sample, several adjustments of chromatographic conditions were tested. The most effective solution was addition of 5 mM ion-pairing agent (namely tetrabutylammonium chloride hydrate) to the mobile phase, together with adjusting pH to 8,0 to support the ionization of the analyte. In the combination with mobile phase modified in this way, a phenyl-hexyl column with retention time 4,36 minutes reached the best result, therefore it was selected for the final determination of...
|
|
L01 DNA damage formation and DNA repair following an intervention of colorectal cell lines with ganoderma lucidum
Vodička, Pavel ; Opattová, Alena ; Čumová, Andrea ; Slíva, D.
Colorectal cancer (CRC) is the third most common malignancy in the world and second most common cause of cancer related deaths in Europe. CRC is complex disease that develops as consequence of environmental and health risk factors with involvement of suboptimal DNA repair, resulting in an accumulation of DNA damage. Reactive oxygen species (ROS) are highly reactive molecules strictly controlled by cellular antioxidant system. Disturbance in the prooxidation–antioxidation homeostasis increases an extent of ROS and consequently an accumulation of DNA damage as well as apoptosis. \nMany natural compounds possess anti-cancer activities tentatively mediated by the generation of ROS. Cancer cells are more sensitive to oxidative DNA damage than non-malignant ones. Modulation of oxidative DNA damage and its repair by natural compounds may lead to selective cancer cell-death and further sensitization of cancer cells to the treatment. Ganoderma Lucidum (GLC) (Reishi, Ling-Zhi), a mushroom used in Chinese medicine for thousands of years, represents an example of a natural compound with empirically recorded anti-cancer as well as anti-proliferative effects. \nThe aim of our study is to define effect of Ganoderma lucidum (GLC) extract on DNA damage and DNA repair system in colorectal cell lines with different genetic backgrounds.\nOur results suggest that GLC extract decreases activity of the cellular antioxidant system which leads to oxidative DNA damage. GLC extract increases genotoxic burden in colorectal cancer cell lines, highlighted by the suppressed base excision repair capacity. These data indicate that specific oxidative DNA damage caused by natural compounds may become a potential tool for the improvement of specific anti-cancer treatment.\n
|
|
Effects of natural substances on DNA damage and repair capacity in colorectal cell lines
Vodenková, Soňa ; Opattová, Alena ; Čumová, Andrea ; Slíva, D. ; Vodička, Pavel
Colorectal carcinoma)CRC) represents serious ilness with high incidence and mortality worldwide. Generaly, there is a lack of reliable predictive and prognostic biomarkers, implicated late diagnosis. The effectivity of treatment is rather low - about 50%. Main agent used in CRC treatment is 5 fluorouracil (5-FU), alone or in combination with other cytostatics. 5-FU is halogenated pyrimidine, which is or directly incorporated into DNA or disrupts thymidine synthesis in tumour cells. This damage is repaired by base excision repair (BBR) or mismatch repair. The aim of this study is to investigate the effect of 5FU together with extracts of Ganoderma lucidum (GL) and the role of BER in various lines of colorectal cancer cell lines. Results show increased oxidative damage after GL and 5FU+GL treatment and in the same time decrease of DNA repair in colorectal cell lines. This fact could contribute to improve of 5FU efficacy.
|
|
Molecular basis of fluoropyrimidine toxic effect etiology with focus on palmar-plantar erythrodysesthesia and potential antidote use
Hartinger, Jan ; Veselý, Pavel (advisor) ; Květina, Jaroslav (referee) ; Brábek, Jan (referee)
(thesis): Palmar-plantar erythrodysesthesia (PPE) frequently accompanies the therapy with a continuous 5-FU infusion or peroral capecitabine (5-FU prodrug). In the most severe cases this adverse effect leads to discontinuation of a needful therapy. Local 10 % uridine ointment is used to prevent and treat the said adverse event. Nevertheless, this method is not generally accepted as an effective one because it has never been proved in a randomized controlled clinical trial. Most probably, a direct effect of a cytostatic compound on the skin of hands and foots causes PPE. The toxicity of 5-FU is mediated primarily by its incorporation into RNA and by thymidylate synthase (TS) inhibition and subsequent DNA synthesis disruption. The importance of particular 5-FU toxicity mechanisms varies in different cell types. For choosing the best PPE local antidote it is necessary to find out which molecular mechanism applies in keratinocytes. We have chosen pyrimidine nucleosides as the most suitable compounds for the local PPE therapy because the uridine ointment is already being used in several oncology centers in the Central Europe. In order to find out the 5-FU toxicity mechanism, we further tested the effect of calciumfolinate (CF) which strengthens the TS inhibition by 5-FU. We studied also uracil and...
|
|
Natural compounds and their effect on 5-fluorouracil in colorectal cancer cell lines
Čumová, Andrea ; Opattová, Alena ; Vodenková, Soňa ; Horák, Josef ; Slíva, D. ; Vodička, Pavel
Colorectal cancer (CRC) is the second most common type of cancer and the second most common cause of cancer related deaths in Europe. 5-Fluorouracil (5-FU) is widely used in treatment of various cancers including CRC, but apart from the cytotoxic effect on cancer cells may also cause adverse toxic side effects. 5-FU is an anti-metabolite with chemical structure similar to that of the pyrimidine molecules of DNA and RNA. However, response to chemotherapy is often limited by drug resistance. The p53 protein is one of the most widely studied tumour suppressors and mutations in TP53 gene are frequently detected in different types of tumours. \nGanoderma Lucidum (GLC) is a mushroom used in Traditional Eastern Medicine which exhibits anti-cancer and anti-proliferative effects in vitro\nThe aim of our study is to define the role of p53 in the interaction between 5-FU and GLC extract and their simultaneous effect on survival in CRC cell lines.\nOur results suggest that GLC extract significantly increases cytotoxicity and genotoxicity of 5-FU in CRC lines with different p53 status and may potentially modulate the response of p53 knock-out cells which are less sensitive to 5-FU treatment. Interaction of conventional chemotherapeutics with natural compounds introduces a novel aspect in cancer research and therapy.\n\n
|
|
Determination of methylation in the promotor regions of genes, that control metabolism of 5-FU
Bendová, Petra ; Vodička, Pavel (advisor) ; Václavíková, Radka (referee)
Several malignant diseases, such as colorectal, pancreatic, breast or ovarial cancers, are primarily treated with cytostatics 5-fluorouracil (5-FU). 5-FU undergoes biotransformation in human body and arising metabolites induce the damage and subsequent apoptosis in the target cells. The main aim of this diploma Thesis was the determination of methylation in promoter regions of 14 candidate genes participating on 5-FU biotransformation: TK1, PPAT, RRM1, RRM2, UCK2, UCK1, UMPS, TYMP, UPP1, UPP 2 SLC29A1, UPB1, DPYS and DPYD. We hypothesize that the methylation in promoter regions regulates mRNA transcription of the above candidate genes. We have conducted appropriate analyses in 128 colorectal cancer patients, for whom both tumor and nonmalignant adjacent tissues were available. Sample processing and analysis involved DNA isolation, bisulfite conversion of unmethylated cytosines to corresponding uracils, methylation-specific analysis of melting curves with high resolution for theproper methylation analysis and gel electrophoresis to separate PCR products. For the majority of the studied genes (TK1, PPAT, RRM1, RRM2, UCK2, UCK1, UMPS, TYMP, UPP1, SLC29A1 and DPYD) we did not detect any aberrant methylation in promoter regions. In genes DPYS, UPB1 and UPP2 we recorded various degree of promoter...
|